SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-257669
Filing Date
2023-10-17
Accepted
2023-10-17 16:13:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d542322d424b5.htm 424B5 331464
2 GRAPHIC g542322g01a25.jpg GRAPHIC 63364
3 GRAPHIC g542322g65e26.jpg GRAPHIC 45139
  Complete submission text file 0001193125-23-257669.txt   475885
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-253008 | Film No.: 231329735
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences